RWS - RWS Share Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for RWS in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RWS shares.
View RWS analyst ratings or view top-rated stocks.

4 analysts have issued 12-month price targets for RWS's shares. Their RWS share price forecasts range from GBX 500 to GBX 690. On average, they predict the company's share price to reach GBX 573.33 in the next twelve months. This suggests a possible upside of 84.9% from the stock's current price.
View analysts price targets for RWS or view top-rated stocks among Wall Street analysts.

RWS's stock was trading at GBX 375.60 at the beginning of the year. Since then, RWS stock has decreased by 17.5% and is now trading at GBX 310.
View the best growth stocks for 2023 here.

RWS Holdings plc (LON:RWS) posted its quarterly earnings results on Tuesday, December, 11th. The company reported $17.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $17.60 by $0.20. RWS had a net margin of 8.37% and a trailing twelve-month return on equity of 5.82%.

RWS declared a dividend on Friday, December 15th. Stockholders of record on Thursday, January 26th will be paid a dividend of GBX 9.50 per share on Friday, February 24th. This represents a dividend yield of 2.74%. The ex-dividend date is Thursday, January 26th. This is a positive change from the stock's previous dividend of GBX 2.25. The official announcement can be viewed at this link.
Read our dividend analysis for RWS.

RWS (LON:RWS) pays an annual dividend of GBX 12 per share and currently has a dividend yield of 3.58%. The dividend payout ratio is 7,500.00%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for RWS.

Based on aggregate information from My MarketBeat watchlists, some companies that other RWS investors own include BioCryst Pharmaceuticals (BCRX), Rolls-Royce Holdings plc (RR), Coca-Cola Amatil (CCLAY), Dynavax Technologies (DVAX), Enbridge (ENB), IQE (IQEPF), RPC Group (RPC), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC) and ASOS (ASC).

RWS trades on the London Stock Exchange (LON) under the ticker symbol "RWS."

Shares of RWS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of RWS stock can currently be purchased for approximately GBX 310.

RWS (LON:RWS) has a market capitalization of £1.21 billion and generates £749.20 million in revenue each year. The company earns £62.70 million in net income (profit) each year or GBX 0.16 on an earnings per share basis.

The company employs 5,295 workers across the globe.

RWS's mailing address is Europa House Chiltern Park, Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom. The official website for the company is www.rws.com. The company can be reached via phone at +44-1753-480200.